Involvement of postnatal gonads in the maturation of dopaminergic regulation of prolactin secretion in male rats. 1987

H Watanobe, and K Takebe

Permanent effects of postnatal gonads on dopamine (DA)-mediated regulation of PRL secretion were examined in adult male rats of the Wistar-Imamichi strain. Rats were bilaterally orchidectomized at varying postnatal days, i.e. 8 h after birth [neonatal castration (NC)] or at 1, 2, 3, 4, or 6 weeks of age, and subjected to experiments at the age of about 10 weeks. Ten-week-old intact adults were also examined. All groups were injected ip with saline or sulpiride (1 mg/kg BW), and blood samples were collected by rapid decapitation 20 min later. Anterior pituitaries (AP) thus obtained were subjected to determination of PRL content. The circulating level of testosterone was similar among all castrated groups. Rats castrated on or after 3 weeks of age showed a significantly smaller PRL response to sulpiride than intact adults. In turn, sulpiride-induced PRL release in rats castrated on or before 2 weeks of age was similar to that in intact adults. However, the AP PRL content of saline control was uniformly lower in castrated males than in intact adults regardless of age at castration (P less than 0.01). The value in males castrated at 1 week was 2.0-fold higher than that in NC males, but a decreasing trend was observed in groups castrated at 2 or 3 weeks. That such a stimulation of AP PRL content by the neonatal testis is not mediated by an action of estradiol converted from testosterone has been suggested by the failure of daily neonatal tamoxifen (estrogen antagonist) treatment of intact males, before castration at 1 week, to decrease AP PRL content during adulthood. Sulpiride-induced reduction of the AP PRL content was significant only in males castrated at 6 weeks and intact adults. Characteristics of AP DA receptors labeled by [3H]spiperone were not different between males castrated at 6 weeks and intact adults. However, a heterogeneity was observed between NC males and a set of males castrated at 6 weeks and intact adults. The Kd was significantly (P less than 0.05) greater in NC males (mean +/- SE, 1.19 +/- 0.22 nM) than in males castrated at 6 weeks (0.52 +/- 0.08 nM), and the number of binding sites was significantly (P less than 0.05) larger in NC males (20.4 +/- 1.6 fmol/pituitary) than in both males castrated at 6 weeks and intact adults (12.6 +/- 2.0 and 13.1 +/- 1.9 fmol/pituitary, respectively).(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D009919 Orchiectomy The surgical removal of one or both testicles. Castration, Male,Orchidectomy,Castrations, Male,Male Castration,Male Castrations,Orchidectomies,Orchiectomies
D010903 Pituitary Gland, Anterior The anterior glandular lobe of the pituitary gland, also known as the adenohypophysis. It secretes the ADENOHYPOPHYSEAL HORMONES that regulate vital functions such as GROWTH; METABOLISM; and REPRODUCTION. Adenohypophysis,Anterior Lobe of Pituitary,Anterior Pituitary Gland,Lobus Anterior,Pars Distalis of Pituitary,Adenohypophyses,Anterior Pituitary Glands,Anterior, Lobus,Anteriors, Lobus,Lobus Anteriors,Pituitary Anterior Lobe,Pituitary Glands, Anterior,Pituitary Pars Distalis
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D013469 Sulpiride A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed) Aiglonyl,Arminol,Deponerton,Desisulpid,Digton,Dogmatil,Dolmatil,Eglonyl,Ekilid,Guastil,Lebopride,Meresa,Pontiride,Psicocen,Sulp,Sulperide,Sulpitil,Sulpivert,Sulpor,Synédil,Tepavil,Vertigo-Meresa,neogama,vertigo-neogama,Vertigo Meresa,vertigo neogama

Related Publications

H Watanobe, and K Takebe
July 1999, Journal of cellular biochemistry,
H Watanobe, and K Takebe
January 1983, Gynecologic and obstetric investigation,
H Watanobe, and K Takebe
January 1981, Brain research,
H Watanobe, and K Takebe
January 1951, Rivista di biologia,
H Watanobe, and K Takebe
March 1986, The Journal of clinical endocrinology and metabolism,
H Watanobe, and K Takebe
December 1988, Clinical and investigative medicine. Medecine clinique et experimentale,
H Watanobe, and K Takebe
January 1985, Hormone research,
H Watanobe, and K Takebe
March 1986, The Journal of endocrinology,
Copied contents to your clipboard!